iBio Inc (IBIO)
1.91
+0.13
(+7.30%)
USD |
NYAM |
Apr 23, 16:00
1.95
+0.04
(+2.09%)
After-Hours: 20:00
iBio Total Liabilities (Quarterly): 24.82M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.82M |
| September 30, 2023 | 24.47M |
| June 30, 2023 | 25.83M |
| March 31, 2023 | 27.00M |
| December 31, 2022 | 32.98M |
| September 30, 2022 | 36.20M |
| June 30, 2022 | 35.92M |
| March 31, 2022 | 35.99M |
| December 31, 2021 | 35.85M |
| September 30, 2021 | 43.21M |
| June 30, 2021 | 38.40M |
| March 31, 2021 | 37.87M |
| December 31, 2020 | 38.08M |
| September 30, 2020 | 37.21M |
| June 30, 2020 | 37.58M |
| March 31, 2020 | 38.26M |
| December 31, 2019 | 36.90M |
| September 30, 2019 | 37.10M |
| June 30, 2019 | 28.13M |
| March 31, 2019 | 28.77M |
| December 31, 2018 | 29.22M |
| September 30, 2018 | 29.87M |
| June 30, 2018 | 26.92M |
| March 31, 2018 | 26.88M |
| December 31, 2017 | 27.03M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.14M |
| June 30, 2017 | 27.10M |
| March 31, 2017 | 27.75M |
| December 31, 2016 | 27.04M |
| September 30, 2016 | 27.39M |
| June 30, 2016 | 27.56M |
| March 31, 2016 | 27.75M |
| December 31, 2015 | 1.538M |
| September 30, 2015 | 1.565M |
| June 30, 2015 | 1.263M |
| March 31, 2015 | 1.254M |
| December 31, 2014 | 1.475M |
| September 30, 2014 | 1.218M |
| June 30, 2014 | 0.395M |
| March 31, 2014 | 1.213M |
| December 31, 2013 | 1.664M |
| September 30, 2013 | 1.653M |
| June 30, 2013 | 4.286M |
| March 31, 2013 | 2.684M |
| December 31, 2012 | 3.088M |
| September 30, 2012 | 3.420M |
| June 30, 2012 | 3.596M |
| March 31, 2012 | 3.801M |
| December 31, 2011 | 4.715M |
| September 30, 2011 | 4.691M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
24.47M
Minimum
Sep 2023
43.21M
Maximum
Sep 2021
34.31M
Average
36.20M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | 0.3139M |
| PAVmed Inc | 57.14M |
| Avalo Therapeutics Inc | 13.69M |
| Imunon Inc | 8.530M |
| Ocugen Inc | 23.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.02M |
| Shareholders Equity (Quarterly) | 9.197M |